{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:05:32Z","timestamp":1781629532844,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1115490"],"award-info":[{"award-number":["OPP1115490"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>High nasopharyngeal pneumococcal carriage density is associated with severe pneumonia; however, little is known about factors that affect pneumococcal carriage density including pneumococcal vaccination. We describe pneumococcal density by clinical and demographic factors, and effect of 13-valent pneumococcal conjugate vaccine (PCV13) on density in Papua New Guinea (PNG), Lao People\u2019s Democratic Republic (Lao PDR) and Mongolia, 3\u20136 years following national PCV13 introduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Three prospective pneumococcal carriage surveillance studies enrolled children aged 2\u201359 months with acute respiratory infections in Lao PDR (2013\u20132019), and pneumonia in PNG (2016\u20132019) and Mongolia (2015\u20132019). Demographic and clinical factors were collected on interview and from medical records. Nasopharyngeal swabs were tested for pneumococci using\n                      <jats:italic>lytA<\/jats:italic>\n                      real-time quantitative PCR and molecular serotyping using DNA microarray. In unvaccinated children median pneumococcal carriage density was compared across relevant clinical and demographic factors using Wilcoxon rank sum or Kruskal Wallis tests. Quantile regression models were used to determine the association between pneumococcal density, vaccination status and number of PCV doses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1009 (PNG), 532 (Lao PDR) and 621 (Mongolia) pneumococcal carriers were included. Of carriers with serotyping results, PCV13 serotype (VT) carriage was 36.1% (356\/985) in PNG, 40.8% (189\/463) in Lao PDR and 50.7% (270\/532) in Mongolia. The median pneumococcal VT density was 6.25 log\n                      <jats:sub>10<\/jats:sub>\n                      GE\/ml (genome equivalents per milliliter) (interquartile range [IQR] 5.66, 6.79) in PNG, 5.74 log\n                      <jats:sub>10<\/jats:sub>\n                      GE\/ml (IQR 4.99, 6.40) in Lao PDR and 5.64 log\n                      <jats:sub>10<\/jats:sub>\n                      GE\/ml (IQR 5.11, 6.32) in Mongolia. In PNG, Lao PDR and Mongolia, 54.4%, 51.1% and 34.9% pneumococcal carriers were fully vaccinated, respectively. There was no difference in VT pneumococcal density by relevant clinical and demographic factors in unvaccinated children. In PNG, VT density was slightly lower (-0.36, 95% confidence interval [CI] -0.61, -0.12;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004) among vaccinated compared with unvaccinated children, in particular those who received three doses (-0.37 95% CI -0.63, -0.10;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). No differences were observed in Lao PDR and Mongolia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We demonstrated variable results across our three sites. Indirect PCV13 effects may have resulted in limited observed reductions in VT density in unvaccinated children. In PNG, PCV13 vaccination was associated with a decline in VT density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12328-w","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:17:40Z","timestamp":1765595860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the effectiveness of the 13-valent pneumococcal conjugate vaccine and clinical and demographic characteristics on pneumococcal carriage density in young children in Papua New Guinea, Lao PDR, and Mongolia"],"prefix":"10.1186","volume":"26","author":[{"given":"Claire","family":"von Mollendorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isatou","family":"Jagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayfong","family":"Mayxay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kim","family":"Mulholland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuya","family":"Mungun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorj","family":"Narangerel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odgerel","family":"Tundev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Nation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cattram D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda D.","family":"Ortika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey L.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joycelyn","family":"Sapura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keoudomphone","family":"Vilivong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A. B.","family":"Dance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Pomat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Satzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the PneuCaPTIVE Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"3","key":"12328_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","volume":"4","author":"D Bogaert","year":"2004","unstructured":"Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to Pneumococcal disease. Lancet Infect Dis. 2004;4(3):144\u201354.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"12328_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1586\/erv.12.53","volume":"11","author":"B Simell","year":"2012","unstructured":"Simell B, Auranen K, Kayhty H, et al. The fundamental link between Pneumococcal carriage and disease. Expert Rev Vaccines. 2012;11(7):841\u201355.","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"12328_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","volume":"16","author":"JN Weiser","year":"2018","unstructured":"Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355\u201367.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"12328_CR4","doi-asserted-by":"publisher","first-page":"e0184762","DOI":"10.1371\/journal.pone.0184762","volume":"12","author":"P Brotons","year":"2017","unstructured":"Brotons P, Bassat Q, Lanaspa M, et al. Nasopharyngeal bacterial load as a marker for rapid and easy diagnosis of invasive Pneumococcal disease in children from Mozambique. PLoS ONE. 2017;12(9):e0184762.","journal-title":"PLoS ONE"},{"issue":"11","key":"12328_CR5","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1097\/INF.0000000000001266","volume":"35","author":"BK Arya","year":"2016","unstructured":"Arya BK, Bhattacharya SD, Sutcliffe CG, et al. Impact of Haemophilus influenzae type B conjugate vaccines on nasopharyngeal carriage in HIV-infected children and their parents from West Bengal, India. Pediatr Infect Dis J. 2016;35(11):e339\u201347.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"12328_CR6","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1093\/aje\/kwz191","volume":"188","author":"CG Sutcliffe","year":"2019","unstructured":"Sutcliffe CG, Grant LR, Cloessner E, et al. Association of laboratory Methods, colonization Density, and age with detection of Streptococcus pneumoniae in the nasopharynx. Am J Epidemiol. 2019;188(12):2110\u20139.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"12328_CR7","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3201\/eid2511.190157","volume":"25","author":"LM Howard","year":"2019","unstructured":"Howard LM, Zhu Y, Griffin MR, et al. Nasopharyngeal Pneumococcal density during asymptomatic respiratory virus infection and risk for subsequent acute respiratory illness. Emerg Infect Dis. 2019;25(11):2040\u20137.","journal-title":"Emerg Infect Dis"},{"key":"12328_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12879-016-1454-x","volume":"16","author":"M Vissers","year":"2016","unstructured":"Vissers M, Ahout IM, van den Kieboom CH, et al. High Pneumococcal density correlates with more mucosal inflammation and reduced respiratory syncytial virus disease severity in infants. BMC Infect Dis. 2016;16:129.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12328_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jinf.2020.06.079","volume":"81","author":"TK Nyazika","year":"2020","unstructured":"Nyazika TK, Law A, Swarthout TD, et al. Influenza-like illness is associated with high Pneumococcal carriage density in Malawian children. J Infect. 2020;81(4):549\u201356.","journal-title":"J Infect"},{"issue":"19","key":"12328_CR10","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1016\/j.vaccine.2023.03.063","volume":"41","author":"I Jagne","year":"2023","unstructured":"Jagne I, von Mollendorf C, Wee-Hee A, et al. A systematic review of Pneumococcal conjugate vaccine impact on Pneumococcal nasopharyngeal colonisation density in children under 5 years of age. Vaccine. 2023;41(19):3028\u201337.","journal-title":"Vaccine"},{"key":"12328_CR11","first-page":"100651","volume":"32","author":"H Smith-Vaughan","year":"2023","unstructured":"Smith-Vaughan H, Temple B, Trang Dai VT, et al. Effect of different schedules of ten-valent Pneumococcal conjugate vaccine on Pneumococcal carriage in Vietnamese infants: results from a randomised controlled trial. Lancet Reg Health West Pac. 2023;32:100651.","journal-title":"Lancet Reg Health West Pac"},{"issue":"8","key":"12328_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1473-3099(23)00061-0","volume":"23","author":"B Temple","year":"2023","unstructured":"Temple B, Tran HP, Dai VTT, et al. Efficacy against Pneumococcal carriage and the immunogenicity of reduced-dose (0\u2009+\u20091 and 1\u2009+\u20091) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet nam: a parallel, single-blind, randomised controlled trial. Lancet Infect Dis. 2023;23(8):933\u201344.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"12328_CR13","doi-asserted-by":"publisher","first-page":"e021512","DOI":"10.1136\/bmjopen-2018-021512","volume":"8","author":"J Chan","year":"2018","unstructured":"Chan J, Nguyen CD, Lai JYR, et al. Determining the Pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type Pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study. BMJ Open. 2018;8(5):e021512.","journal-title":"BMJ Open"},{"key":"12328_CR14","unstructured":"UNICEF, Organization WH, Bank W et al. Estimates developed by the UN Inter-agency Group for Child Mortality Estimation. https:\/\/childmortality.org\/ (Accessed 27 Dec 2024)."},{"key":"12328_CR15","unstructured":"World Health Organization. Estimates of National Immunization Coverage. 2023. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/pneumococcal-vaccination-coverage (Accessed 27 Dec 2024)."},{"issue":"1","key":"12328_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12889-019-6639-y","volume":"19","author":"SF La Vincente","year":"2019","unstructured":"La Vincente SF, von Mollendorf C, Ulziibayar M, et al. Evaluation of a phased Pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a study protocol for a prospective observational study and lessons learned. BMC Public Health. 2019;19(1):333.","journal-title":"BMC Public Health"},{"issue":"1","key":"12328_CR17","doi-asserted-by":"publisher","first-page":"e0361522","DOI":"10.1128\/spectrum.03615-22","volume":"11","author":"ML Nation","year":"2023","unstructured":"Nation ML, Manna S, Tran HP, et al. Impact of COVID-19 nonpharmaceutical interventions on Pneumococcal carriage prevalence and density in Vietnam. Microbiol Spectr. 2023;11(1):e0361522.","journal-title":"Microbiol Spectr"},{"key":"12328_CR18","doi-asserted-by":"crossref","unstructured":"von Mollendorf C, Mungun T, Ulziibayar M et al. Effect of Pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2\u201359 months in mongolia: an active pneumonia surveillance programme. Lancet Microbe 2024: 100929.","DOI":"10.1016\/S2666-5247(24)00171-X"},{"issue":"2","key":"12328_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.vaccine.2018.10.077","volume":"37","author":"C Satzke","year":"2019","unstructured":"Satzke C, Dunne EM, Choummanivong M, et al. Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent Pneumococcal conjugate vaccine. Vaccine. 2019;37(2):296\u2013305.","journal-title":"Vaccine"},{"issue":"38","key":"12328_CR20","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1016\/j.vaccine.2021.07.085","volume":"39","author":"KJ Britton","year":"2021","unstructured":"Britton KJ, Pickering JL, Pomat WS, et al. Lack of effectiveness of 13-valent Pneumococcal conjugate vaccination against Pneumococcal carriage density in Papua new Guinean infants. Vaccine. 2021;39(38):5401\u20139.","journal-title":"Vaccine"},{"issue":"1","key":"12328_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","volume":"32","author":"C Satzke","year":"2013","unstructured":"Satzke C, Turner P, Virolainen-Julkunen A, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the world health organization Pneumococcal carriage working group. Vaccine. 2013;32(1):165\u201379.","journal-title":"Vaccine"},{"issue":"11","key":"12328_CR22","doi-asserted-by":"publisher","first-page":"e1001903","DOI":"10.1371\/journal.pmed.1001903","volume":"12","author":"C Satzke","year":"2015","unstructured":"Satzke C, Dunne EM, Porter BD, et al. The PneuCarriage project: A Multi-Centre comparative study to identify the best serotyping methods for examining Pneumococcal carriage in vaccine evaluation studies. PLoS Med. 2015;12(11):e1001903.","journal-title":"PLoS Med"},{"key":"12328_CR23","unstructured":"World Health Organization. Integrated Management of Childhood Illness: Chart booklet 2014. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/104772\/9789241506823_Chartbook_eng.pdf (Accessed 4 Sep 2022)."},{"key":"12328_CR24","doi-asserted-by":"crossref","unstructured":"Chan J, Lai JYR, Nguyen CD et al. Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People\u2019s Democratic Republic. BMJ Glob Health 2021; 6(6).","DOI":"10.1136\/bmjgh-2021-005187"},{"key":"12328_CR25","doi-asserted-by":"crossref","unstructured":"Chan J, Mungun T, Batsaixan P et al. Direct and indirect effects of 13-valent Pneumococcal conjugate vaccine on Pneumococcal carriage in children hospitalised with pneumonia from formal and informal settlements in mongolia: an observational study. Lancet Reg Health \u2013 Western Pac 2021; 15.","DOI":"10.1016\/j.lanwpc.2021.100231"},{"issue":"1","key":"12328_CR26","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1038\/s41467-024-50944-3","volume":"15","author":"C von Mollendorf","year":"2024","unstructured":"von Mollendorf C, Mungun T, Ulziibayar M, et al. Effect of Pneumococcal conjugate vaccine six years post-introduction on Pneumococcal carriage in Ulaanbaatar, Mongolia. Nat Commun. 2024;15(1):6577.","journal-title":"Nat Commun"},{"issue":"19","key":"12328_CR27","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1016\/j.vaccine.2024.05.018","volume":"42","author":"R Kandasamy","year":"2024","unstructured":"Kandasamy R, Gurung M, Shrestha S, et al. Decline in Pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study. Vaccine. 2024;42(19):4066\u201371.","journal-title":"Vaccine"},{"issue":"7","key":"12328_CR28","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1164\/rccm.201503-0542OC","volume":"192","author":"AM Collins","year":"2015","unstructured":"Collins AM, Wright AD, Mitsi E, et al. First human challenge testing of a Pneumococcal Vaccine. Double-Blind randomized controlled trial. Am J Respir Crit Care Med. 2015;192(7):853\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"12328_CR29","doi-asserted-by":"publisher","unstructured":"Ford R, Neal E, Sapura J et al. Association between village coverage of 13-valent pneumococcal conjugate vaccine and vaccine-type pneumococcal carriage among children aged 0\u201359 months with pneumonia in Papua New Guinea: an observational study. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-5390905\/v1 (Accessed 27 Dec 2024).","DOI":"10.21203\/rs.3.rs-5390905\/v1"},{"issue":"34","key":"12328_CR30","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1016\/j.vaccine.2016.06.017","volume":"34","author":"C Valente","year":"2016","unstructured":"Valente C, Hinds J, Gould KA, et al. Impact of the 13-valent Pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage. Vaccine. 2016;34(34):4072\u20138.","journal-title":"Vaccine"},{"key":"12328_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ijid.2023.07.007","volume":"134","author":"LM Howard","year":"2023","unstructured":"Howard LM, Huang X, Chen W, et al. Association between nasopharyngeal colonization with multiple Pneumococcal serotypes and total Pneumococcal colonization density in young Peruvian children. Int J Infect Dis. 2023;134:248\u201355.","journal-title":"Int J Infect Dis"},{"key":"12328_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijid.2019.06.024","volume":"86","author":"C Murad","year":"2019","unstructured":"Murad C, Dunne EM, Sudigdoadi S, et al. Pneumococcal carriage, density, and co-colonization dynamics: A longitudinal study in Indonesian infants. Int J Infect Dis. 2019;86:73\u201381.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"12328_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/cid\/cis554","volume":"55","author":"A Roca","year":"2012","unstructured":"Roca A, Bottomley C, Hill PC, et al. Effect of age and vaccination with a Pneumococcal conjugate vaccine on the density of Pneumococcal nasopharyngeal carriage. Clin Infect Dis. 2012;55(6):816\u201324.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"12328_CR34","doi-asserted-by":"publisher","first-page":"e0224392","DOI":"10.1371\/journal.pone.0224392","volume":"14","author":"EM Dunne","year":"2019","unstructured":"Dunne EM, Choummanivong M, Neal EFG, et al. Factors associated with Pneumococcal carriage and density in infants and young children in Laos PDR. PLoS ONE. 2019;14(10):e0224392.","journal-title":"PLoS ONE"},{"issue":"suppl3","key":"12328_CR35","doi-asserted-by":"publisher","first-page":"S317","DOI":"10.1093\/cid\/cix100","volume":"64","author":"HC Baggett","year":"2017","unstructured":"Baggett HC, Watson NL, Deloria Knoll M, et al. Density of upper respiratory colonization with Streptococcus pneumoniae and its role in the diagnosis of Pneumococcal pneumonia among children Aged\u2009<\u20095 years in the PERCH study. Clin Infect Dis. 2017;64(suppl3):S317\u201327.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"12328_CR36","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1093\/infdis\/jiab239","volume":"225","author":"OJJ Carr","year":"2022","unstructured":"Carr OJJ, Vilivong K, Bounvilay L, et al. Nasopharyngeal Pneumococcal colonization density is associated with severe pneumonia in young children in the Lao people\u2019s Democratic Republic. J Infect Dis. 2022;225(7):1266\u201373.","journal-title":"J Infect Dis"},{"key":"12328_CR37","doi-asserted-by":"crossref","unstructured":"Fan RR, Howard LM, Griffin MR, Nasopharyngeal Pneumococcal Density and Evolution of Acute Respiratory Illnesses in Young, Children P et al. 2009\u20132011. Emerg Infect Dis 2016; 22(11): 1996-9.","DOI":"10.3201\/eid2211.160902"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12328-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:28:14Z","timestamp":1781627294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12328-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12328"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12328-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written parent or guardian consent was obtained for study enrolment. The study was conducted according to protocols approved by the following ethics committees: Lao PDR Ministry of Health National Ethics Committee for Health Research (057\/2013 NECHR), Oxford Tropical Research Ethics Committee (1050-13), Mongolian National Ethics Committee for Health Research, the WHO Regional Office for the Western Pacific (WPRO) Ethics Review Committee (2013.30.LAO.2.EPI, Mongolia), PNG IMR Institutional Review Board (1510), Government of PNG Medical Research Advisory Committee (15.18) and the Royal Children\u2019s Hospital\/MCRI Human Research Ethics Committee (33177 and 33203).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EKM, CDN, CS, TM and CVM are investigators on a separate study that received grant funding from Pfizer. CS, CDN and EKM are investigators on a Merck Investigator Studies Program grant funded by MSD for a study unrelated to this work. CVM and CS have received honoraria from Pfizer and MSD for presentations at symposia or attendance at expert advisory meetings unrelated to this study. WSP has received grant funding and travel reimbursements from Pfizer. CCB has received grant funding from Pfizer.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}